Select Bibliography

Filter by any of these (after searching):

Rai, Kanti

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 6 items

Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.

Byrd, John C , Peterson, Bercedis L , Rai, Kanti R , Hurd, David ... - - Leuk Lymphoma - 2009

Manuscript - Primary - Primary - Leukemia - CALGB-19901

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Lin, Thomas S. , Donohue, Kathleen A. , Byrd, John C. ... - - J Clin Oncol - 2010

Manuscript - Primary - Primary - Leukemia - CALGB-10101

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study

Lozanski, Gerard , Ruppert, Amy S. , Heerema, Nyla A. ... - - Leuk Lymphoma - 2012

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-9712 , CALGB-9665

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).

Solh, Melhem , Rai, Kanti R , Peterson, Bercedis L ... - - Leuk Lymphoma - 2013

Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9011

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712

Woyach, Jennifer A. , Ruppert, Amy S. , Heerema, Nyla A. ... - - J Clin Oncol - 2011

Manuscript - Primary - Long-Term-Followup - Leukemia - CALGB-9712

Impact of Age on Outcomes After Initial Therapy With Chemotherapy and Different Chemoimmunotherapy Regimens in Patients With Chronic Lymphocytic Leukemia: Results of Sequential Cancer and Leukemia Group B Studies

Woyach, Jennifer A. , Ruppert, Amy S. , Rai, Kanti , Lin, Thomas S. ... - - J Clin Oncol - 2013

Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-9011 , CALGB-9712 , CALGB-19901 , CALGB-10101